RNS Number : 3921G
IP Group PLC
25 November 2020
|
FOR RELEASE ON
|
25 November 2020
|
Director Declaration
IP Group plc (LSE: IPO) ("the Group"), the developer of intellectual property-based businesses, confirms that Elaine Sullivan, a non-executive director of the Group, has been appointed as a director of Open Orphan plc and Active Biotech AB.
This disclosure is made in accordance with LR 9.6.14R of the Listing Rules.
For more information, please contact:
|
IP Group plc
|
www.ipgroupplc.com
|
|
Angela Leach, Company Secretary
Liz Vaughan-Adams, Communications
|
+44 (0) 20 7444 0050
+44 (0) 20 7444 0062/+44 (0) 7979 853802
|
Notes for editors
About IP Group
IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at
www.ipgroupplc.com
.
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
RDNKKQBDCBDDFDB
|
